Bayer Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What we have seen a few days ago. Aude up by over 1 despite cut in the outlook for global oil demand, yet still see i still seeing some kind of rally in place. We bring you this mornings market moving news from all around the world. Joining us is bloombergs enda leon, emmanando good chandra, and michael mckee. Walk us through what we learned from the inflation front. Enda we had refractory data that should inflation in threed, the first years. It suggests factories in china are heading into deflationary territory. That is a clear negative for profits, and it will make it much harder to repay d...

China. Xi jinping ahead of talks with President Trump before the g20. Bayer shares jump as the German Chemicals group bolsters its legal team to address a multibillion dollar litigation challenge around its roundup we weed killer. And h m reports sales of its summer collection are off to a strong start with the firms shares on course for their best day in three months. Good morning a bit of italian data this morning. Italy june Consumer Confidence numbers are just out theyve fallen to 109. 6 verses a consensus of 111. 3 this is the lowest italian Consumer Confidence number since july 2017. Ove...

NOTICE OF MEETING AND MANAGEMENT PROXY CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS ...

Momentum in funding raised by private equity (PE) and venture capital (VC) picked up further this week, mainly propelled by a couple of big-ticket transactions ......

Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited (BZPPL), established in 2011 for pharmaceutical sales and marketing in India. Bayer is now acquiring full ownership of the entity as per pre-agreed terms. The joint venture successfully combined Zydus's Indian marketing expertise and distribution network with Bayer's global innovation, making strides in various therapeutic areas.